Home > News > Headline News > Archive

Click on title to read the full article.

Study: PET confirms efficacy of estrogen-blocking drugs

August 23, 2011

By Justine Cadet

18F-fluoroestradiol (FES) PET can assess the in vivo pharmacodynamics of estrogen receptor (ER)-targeted agents and may give insight into the activity of established therapeutic agents, according to a study in the August issue of Clinical Cancer Research

Cancer’s Secrets Come Into Sharper Focus

August 16, 2011

By George Johnson, New York Times

For the last decade cancer research has been guided by a common vision of how a single cell, outcompeting its neighbors, evolves into a malignant tumor.

Herceptin Heart Risks Clarified for Older Patients

August 11, 2011

By Charles Bankhead

Older breast cancer patients with heart disease or diabetes have a significantly increased risk of cardiotoxicity when treated with trastuzumab (Herceptin), according to data from a single-center chart review.

Small Molecules Found to Play Complex Roles in Cancer Metastasis

August 9, 2011

By Cancer Institute of N. J.

While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another.

Genentech Takes Another Shot at Convincing FDA to Maintain Avastin’s Metastatic Breast Cancer Approval

August 6, 2011

Intent on persuading FDA commissioner Margaret A. Hamburg, M.D., to retain Avastin’s metastatic breast cancer (MBC) indication, Genentech has restated its proposal to conduct a new confirmatory Phase III trial of the drug with the chemo drug paclitaxel in Her2-negative MBC.

Conference to explore ways of treating metastatic breast cancers

August 5, 2011

New treatments for metastatic breast cancer are needed, as many patients become resistant to existing therapies.

Why it Makes Sense to Keep Avastin Available for Women with Metastatic Breast Cancer

August 4, 2011

By Dr. Elaine Schattner

The reason I believe Avastin should be available for breast cancer treatment is that it helps a fraction of women, albeit a small one, to live active, enjoyable lives.